Generic Name |
Imatinib + Fampridine | |
|---|---|---|
IND |
||
Brand Name (US) |
||
Manufacturer |
||
Drug Type |
||
Delivery |
Oral | |
Approval Status |
||
Indications |
||
Overall Strategy |
Synthetic lethality | |
Strategy |
Inhibit cell proliferation and migration/invasion, as well as induce apoptosis | |
Drug Category |
KIT + VGKC inhibitor | |
Links |
|
Trials of this drug |
|
|
Neoadjuvant Imatinib and Fampridine in KIT Mutant Gastrointestinal Stromal Tumor |
Trial results |
|